Petra Pharma racks up $48 mln Series A
Petra Pharma Corp, a startup focused on treating cancer and metabolic diseases that was launched by Accelerator Corp, has raised $48 million in Series A funding. The investors included AbbVie, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Harris & Harris Group, Inc., Innovate NY Fund, Johnson & Johnson Innovation – JJDC, Inc, The Partnership Fund for New York City, Pfizer Venture Investments, Watson Fund and WuXi PharmaTech.
6 January 2016•4 mins read
